203 related articles for article (PubMed ID: 9112675)
1. Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosis.
Krupiński K; Giedrojć J; Breddin HK; Bielawiec M
Pol J Pharmacol; 1996; 48(3):345-50. PubMed ID: 9112675
[TBL] [Abstract][Full Text] [Related]
2. [Antithrombotic properties of heparin independent of its anticoagulant activity].
Krupiński K; Bielawiec M; Breddin HK
Acta Haematol Pol; 1994; 25(3):243-51. PubMed ID: 7992597
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the antithrombotic effects of pentoxifylline, acetylsalicylic acid and low molecular weight heparin in the laser model of thrombosis].
Krupiński K; Breddin HK; Bielawiec M; Płonowski A
Kardiol Pol; 1992 Mar; 36(3):142-5. PubMed ID: 1318982
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the sulfated lactobionic acid (LW 10082) and other antithrombotic agents in animal thrombosis model.
Giedrojć J; Krupiński K; Breddin HK; Bielawiec M
Pol J Pharmacol; 1996; 48(3):317-22. PubMed ID: 9112669
[TBL] [Abstract][Full Text] [Related]
5. [Antithrombotic effects of molsidomine, isosorbide dinitrate and verapamil in a laser-induced thrombosis model].
Krupiński K; Breddin H; Bielawiec M
Kardiol Pol; 1993 Aug; 39(8):100-4. PubMed ID: 8231003
[TBL] [Abstract][Full Text] [Related]
6. Effect of troxerutin on laser-induced thrombus formation in rat mesenteric vessels, coagulation parameters and platelet function.
Krupiński K; Giedrojć J; Bielawiec M
Pol J Pharmacol; 1996; 48(3):335-9. PubMed ID: 9112673
[TBL] [Abstract][Full Text] [Related]
7. The arterial antithrombotic activity of thioxylosides in a rat model of laser-induced thrombosis.
Aguejouf O; Oualane FA; Inamo J; Imbault P; Doutremepuich F; Millet J; Theveniaux J; Doutremepuich C
Semin Thromb Hemost; 1996; 22(4):327-33. PubMed ID: 8944417
[TBL] [Abstract][Full Text] [Related]
8. Effects of combinations of a molsidomin with different antithrombotic drugs in laser-induced thrombosis.
Giedrojć J; Bielawiec M; Jaromin J; Breddin HK
Mater Med Pol; 1993; 25(3-4):153-7. PubMed ID: 8072321
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic efficacy in a rat model of the low molecular weight heparin, reviparin sodium, administered by the oral route.
Hiebert LM; Wice SM; Ping T; Herr D; Laux V
Thromb Haemost; 2001 Jan; 85(1):114-8. PubMed ID: 11204561
[TBL] [Abstract][Full Text] [Related]
10. The antithrombotic effect of thromboxane receptor antagonist HN 11500 on thrombus formation in laser thrombosis model and platelet function tests.
Krupiński K; Ferber H; Breddin HK; Bielawiec M
Acta Haematol Pol; 1994; 25(3):235-42. PubMed ID: 7992596
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic effect of a recombinant von Willebrand factor, VCL, on nitrogen laser-induced thrombus formation in guinea pig mesenteric arteries.
Azzam K; Garfinkel LI; Bal dit Sollier C; Cisse Thiam M; Drouet L
Thromb Haemost; 1995 Feb; 73(2):318-23. PubMed ID: 7792749
[TBL] [Abstract][Full Text] [Related]
13. Experimental studies on the anticoagulant and antithrombotic effects of sodium and calcium pentosan polysulphate.
Giedrojć J; Radziwon P; Klimiuk M; Bielawiec M; Breddin HK; Kłoczko J
J Physiol Pharmacol; 1999 Mar; 50(1):111-9. PubMed ID: 10210159
[TBL] [Abstract][Full Text] [Related]
14. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
Kaiser B; Hauptmann J; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on the low molecular weight heparin derivative CY 216.
Kaiser B; Kühnemuth G; Markwardt F
Pharmazie; 1990 Jul; 45(7):522-4. PubMed ID: 2173004
[TBL] [Abstract][Full Text] [Related]
16. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
17. Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats.
Costantini V; Deveglia R; Stabile A; Nenci GG
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):7-13. PubMed ID: 10691095
[TBL] [Abstract][Full Text] [Related]
18. Effect of low molecular weight fucoidan and low molecular weight heparin in a rabbit model of arterial thrombosis.
Durand E; Helley D; Al Haj Zen A; Dujols C; Bruneval P; Colliec-Jouault S; Fischer AM; Lafont A
J Vasc Res; 2008; 45(6):529-37. PubMed ID: 18463418
[TBL] [Abstract][Full Text] [Related]
19. Effect of low-molecular-weight heparins on laser-induced thrombus formation in rat mesenteric vessels.
Weichert W; Breddin HK
Haemostasis; 1988; 18 Suppl 3():55-63. PubMed ID: 2840375
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
